Prevalence of antibodies to alphaviruses and flaviviruses in free-ranging game animals and nonhuman primates in the greater Congo basin

Journal of Wildlife Diseases

Volumn 49, Issue 3, 2013, Pages 587-599

  Kading, Rebekah C ^a   Borland, Erin M ^a   Cranfield, Mike ^b   Powers, Ann M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Maryland Zoo in Baltimore   (United States)

Author keywords

Arbovirus; Congo basin; Emerging viruses; Primates; Surveillance; Wildlife

Indexed keywords

VIRUS ANTIBODY;

ALPHA VIRUS; ALPHAVIRUS INFECTION; ANIMAL; ANIMAL DISEASE; ARBOVIRUS; ARTICLE; BLOOD; BUFFALO; CONGO; CONGO BASIN; DISEASE CARRIER; ELEPHANT; EMERGING VIRUSES; EPIDEMIOLOGY; FEMALE; FLAVIVIRUS; FLAVIVIRUS INFECTION; GORILLA; IMMUNOLOGY; MALE; MANDRILLUS; PAN TROGLODYTES; PRIMATE; SURVEILLANCE; WILD ANIMAL; WILDLIFE;

ARBOVIRUS; CONGO BASIN; EMERGING VIRUSES; PRIMATES; SURVEILLANCE; WILDLIFE;

ALPHAVIRUS; ALPHAVIRUS INFECTIONS; ANIMALS; ANIMALS, WILD; ANTIBODIES, VIRAL; BUFFALOES; CONGO; DISEASE RESERVOIRS; ELEPHANTS; FEMALE; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; GORILLA GORILLA; MALE; MANDRILLUS; PAN TROGLODYTES; PRIMATES; SEROEPIDEMIOLOGIC STUDIES;

ALPHAVIRUS; ANIMALIA; ARBOVIRUS; ARTHROPODA; CEPHALOPHUS; CERCOPITHECUS; CERCOPITHECUS LHOESTI; CHIKUNGUNYA VIRUS; DENGUE VIRUS TYPE 2; ELEPHANTIDAE; FLAVIVIRUS; GORILLA GORILLA BERINGEI; GORILLA GORILLA GRAUERI; LOXODONTA; LOXODONTA AFRICANA; MANDRILLUS SPHINX; O'NYONG-NYONG VIRUS; PAN; PAN TROGLODYTES; PHILANTOMBA; PRIMATES; SYNCERUS CAFFER NANUS; WEST NILE VIRUS; YELLOW FEVER VIRUS;

EID: 84879169816     PISSN: 00903558     EISSN: None     Source Type: Journal    
DOI: 10.7589/2012-08-212     Document Type: Article

References (32)

1. Al-Busaidy S, Hamblin C, Taylor WP. 1987. Neutralizing antibodies to Akabane virus in freeliving wild animals in Africa. Trop Anim Health Prod 19:197-202.
2. Amarasinghe A., Kuritsky JN, William Letson G, Margolis HS. 2011. Dengue virus infection in Africa. Emerg Infect Dis 17:1349-1354.
3. Bauer J.H., Mahaffy AF. 1930. Susceptibility of African monkeys to yellow fever. Am J Hyg 12:155-174.
4. Beaty B.J., Calisher CH, Shope RE. 1995. Arboviruses. In: Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections. 7th Ed., Lennette EH, Lennette DA and Lennette ET, editors. American Public Health Association, Washington DC, pp. 189-212.
5. Binepal V.S., Wariru BN, Davies FG, Soi R, Olubauyo R. 1992. Vet Microbiol 31:19-23.
6. Chanas A.C., Hubalek Z, Johnson BK, Simpson DI. 1979. A comparative study of O'nyong nyong virus with Chikungunya virus and plaque variants. Arch Virol 59:231-238.
7. Charrel R.N., De Lamballerie X, Raoult D. 2007. Chikungunya outbreaks-The globalization of vectorborne diseases. New Engl J Med 356:769-771.
8. Crabtree M.B., Kading RC, Mutebi JP, Lutwama JJ, Miller BR. 2013. Identification of host blood from engorged mosquitoes collected in western Uganda using cytochrome oxidase I gene sequences. J Wildlife Dis 49:611-626.
9. Childs J.E., Gordon ER. 2009. Surveillance and control of zoonotic agents prior to disease detection in humans. Mt Sinai J Med 76:421-428.
10. Daszak P., Epstein JH, Kilpatrick AM, Aguirre AA, Karesh W.B., Cunningham AA. 2007. Collaborative research approaches to the role of wildlife in zoonotic disease emergence. Curr Top Microbiol Immunol 315:463-475.
11. Diallo M., Nabeth P, Ba K, Sal AA, Bâ Y, Mond M, Girault L., Abdalahi MO, Mathiot C. 2005. Mosquito vectors of the 1998-1999 outbreak of Rift Valley fever and other arboviruses (Bagaza, Sanar, Wesselsbron and West Nile) in Mauritania and Senegal. Med Vet Entomol 19:119-126.
12. Duffy M.R., Chen TH, Hancock WT, Powers AM, Kool J.L., Lanciotti RS, Pretrick M, Marfel M, Holzbauer S., Dubray C, et al. 2009. Zika virus outbreak on Yap Island, Federated States of Micronesia. New Engl J Med 360:2536-2543.
13. Dwyer D.E., Kirkland PD. 2011. Influenza: One Health in action. New South Wales Public Health Bull 22:123-126.
14. Evans A., Gakuya F, Paweska JT, Rostal M, Akoolo L, VanVuren PJ, Manyibe T, Macharia JM, Ksiazek TG, Feikin DR, et al. 2008. Epidemiol Infect 136:1261-1269.
15. Haddow AJ. 1968. The natural history of yellow fever in Africa. Proc R Soc Edinb B 70:191-227.
16. Hubálek Z., Halouzka J. 1999. West Nile fever-A reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis 5:643-650.
17. Jones K.E., Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. 2008. Global trends in emerging infectious diseases. Nature 451:990-994.
18. Kirya B.G., Okia NO. 1977. A yellow fever epizootic in Zika forest, Uganda, during 1972: Part 2: Monkey serology. Trans R Soc Trop Med Hyg 71:300-303.
19. Lanciotti R.S., Roehrig J T, Deubel V, Smith J, Parker M, Steele K, Crise B, Volpe KE, Crabtree MB, Scherret J.H., et al. 1999. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286:2333-2337.
20. Leroy E.M., Nkoghe D, Ollomo B, Nze-Nkogue C, Becquart P., Grard G, Pourrut X, Charrel R, Moureau G., Ndjoyi-Mbiguino A, et al. 2009. Concurrent chikungunya and dengue virus infections during simultaneous outbreaks, Gabon, 2007. Emerg Infect Dis 15:591-593.
21. McCrae AWR, Henderson BE, Kirya BG, Sempala SDK. 1971. Chikungunya virus in the Entebbe area of Uganda: Isolations and epidemiology. Trans R Soc Trop Med Hyg 65:152-168.
22. McIntosh BM. 1986. Mosquito-borne virus diseases of man in southern Africa. S Afr Med J 70:69-72.
23. Saluzzo J.F., Ivanoff B, Languillat G, Georges AJ. 1982. Serological survey for arbovirus antibodies in the human and simian populations of the south-east of Gabon. Bull Soc Pathol Exot 75:262-266.
24. Sekyalo E., Mujomba E, Mukuyo A. 1974. Serology. East Afr Virus Res Inst Report 24:12-20.
25. Taylor L.H., Latham SM, Woolhouse MEJ. 2001. Risk factors for human disease emergence. Philos Trans R Soc Lond B 356:983-989.
26. Traoré-Lamizana M, Fontenille D, Diallo M, Bâ Y, Zeller H.G., Mondo M, Adam F, Thonon J Maïga A. 2001. Arbovirus surveillance from 1990 to 1995 in the Barkedji area (Ferlo) of Senegal, a possible natural focus of Rift Valley fever virus. J Med Entomol 38:480-492.
27. United States Agency for International Development. USAID launches emerging pandemic threats program. Press release: October 21, 2009, http:// www.usaid.gov/news-information/press-releases/ usaid-launches-emerging-pandemic-threats-program. Accessed January 2013.
28. Vázquez A., Jiménez-Clavero MA, Franco L, Donoso-Mantke O., Sambri V, Niedrig M, Zeller H, Tenorio A. 2011. Usutu virus-Potential risk of human disease in Europe. Eurosurveillance 16:pii519935.
29. Wang E., Ni H, Xu R, Barrett AD, Watowich SJ, Gubler D.J., Weaver SC. 2000. Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol 74:3227-3234.
30. Weaver S.C., Reisen WK. 2010. Present and future arboviral threats. Antivir Res 85:328. doi:10. 1016/j.antiviral.2009.10.008.
31. Weinbren M.P., Hewitt LE. 1959. Virus neutralization tests on hippopotamus sera. Report of the East African Virus Research Institute, East African High Commission, Government Printer, Nairobi, Kenya, pp. 13-15.
32. WoolhouseM, Gaunt E. 2007. Ecological origins of novel human pathogens. Crit Rev Microbiol 33:231-242.